🦊/People

Nate Chang

Investor

Director Of Finance at Owl Ventures · Operating Partner, Life Sciences at Playground Global

San Francisco Bay Area

Find your path to Nate

109 people in our graph share verified history with Nate — schools, employers, funds. One of them is your warm intro.

Ted NeelyunlockedNate: together at Owl Ventures (2017–2026)
×6Nate: together at Owl Ventures
×5Nate: together at Playground Global

About

Nate Chang began his venture capital career as a Partner on Andreessen Horowitz's Corporate Development team, where he advised a16z Bio portfolio companies on strategic plans including fundraising, capital markets readiness, M&A and business development. Before a16z, he spent 14 years in healthcare investment banking covering life science companies at Credit Suisse, Morgan Stanley and RBC Capital Markets, and earlier worked as a clinical research associate at Quintiles and in business development at Pharmaceutical Product Development. He holds an MBA from the Tuck School of Business at Dartmouth College and studied Molecular Biology and Applied Mechanics (Bioengineering) at UC San Diego.

Invests in

BiotechHealthtech

Colleagues at Owl Ventures

Frequently asked questions

Who is Nate Chang?
Nate Chang began his venture capital career as a Partner on Andreessen Horowitz's Corporate Development team, where he advised a16z Bio portfolio companies on strategic plans including fundraising, capital markets readiness, M&A and business development. Before a16z, he spent 14 years in healthcare investment banking covering life science companies at Credit Suisse, Morgan Stanley and RBC Capital Markets, and earlier worked as a clinical research associate at Quintiles and in business development at Pharmaceutical Product Development. He holds an MBA from the Tuck School of Business at Dartmouth College and studied Molecular Biology and Applied Mechanics (Bioengineering) at UC San Diego.
Where does Nate Chang work?
Nate Chang is Director Of Finance at Owl Ventures.
What does Nate Chang invest in?
Nate Chang invests in Biotech, Healthtech.